1. Vaccination against Her-2/neu, with focus on peptide-based vaccines.
    J Tobias et al, 2022, ESMO Open CrossRef
  2. Hypersensitivity Reactions to Monoclonal Antibodies: New Approaches
    Sonia Gelis et al, 2022, Curr Treat Options Allergy CrossRef
  3. Biological products in medicine
    Marzieh Daniali et al, 2022 CrossRef
  4. HLAII peptide presentation of infliximab increases when complexed with TNF
    Andrea Casasola-LaMacchia et al, 2022, Front. Immunol. CrossRef
  5. Biopharmaceuticals against substance use disorders – Present and future
    Theofanis Vavilis et al, 2023, European Journal of Pharmacology CrossRef
  6. Immune Reactions in Major Types of Oncological Treatment
    Patrycja Kozubek et al, 2023, IJMS CrossRef
  7. Managing Severe Adverse Reactions to Biologicals in Severe Asthma
    Radu-Gheorghe Balan et al, 2023, Biomedicines CrossRef
  8. Rational design of antibody‐like peptides for targeting the human complement fragment protein C5a
    Manaswini Ghosh et al, 2024, Proteins CrossRef
  9. Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections
    Adam J. Gehring et al, 2024, Antiviral Research CrossRef
  10. Therapeutic Applications of Aptamers
    George Santarpia et al, 2024, IJMS CrossRef
  11. Immunogenicity of biologics used in the treatment of asthma
    Omario A.M. Neunie et al, 2024, HAB CrossRef
  12. EVALUATION OF DRUG SIDE EFFECT PROFILES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE USING TUMOR NECROSIS FACTOR-ALPHA INHIBITORS
    Ceren Demir et al, 2024, qrheumatol CrossRef
  13. Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer
    Joshua Tobias et al, 2022, Cancers CrossRef
  14. Severe hypersensitivity reactions to 2 immunotherapy agents in a patient with cutaneous squamous cell carcinoma
    Justin C Liauw et al, 2024 CrossRef
  15. Reasons and Predictors of Treatment Change in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Single-Center Retrospective Observational Study
    Chihiro Nakagawa et al, 2024, Biological & Pharmaceutical Bulletin CrossRef
  16. Unveiling Awareness: Exploring Antibiotic Hypersensitivity among International Islamic University Malaysia (IIUM) Undergraduates in Kuantan, Pahang
    Suhada Sepian et al, 2024, Int J Care Scholars CrossRef
  17. Superficial mucoceles as a sequel to Stevens‑Johnson syndrome during treatment of cutaneous squamous cell carcinoma with cemiplimab: A case report and review of literature
    Vasiliki Chwiałkowska et al, 2024, Exp Ther Med CrossRef